Camellia sinensis– Derived Ingredients: CIR Safety Assessment Summary
CIR safety assessment summary for Camellia sinensis– Derived Ingredients: ingredients reviewed, panel verdict, use concentration context, conditions, and.
Camellia sinensis– Derived Ingredients appears in a CIR safety assessment covering Camellia sinensis– Derived Ingredients. The panel verdict for the report is safe with restrictions. The CIR Panel concluded that Camellia Sinensis Leaf–derived ingredients are safe as used in cosmetic products when formulated to be nonsensitizing. These are: *Not is use.
| Field | CIR value |
|---|---|
| Primary ingredient | Camellia sinensis– Derived Ingredients |
| CIR verdict | safe with restrictions |
| Report type | Safety Assessment |
| Date | 2019 |
| CAS numbers | 84650-60-2, 1196791-49-7, 68916-73-4 |
| Conditions or carve-outs | The CIR Panel concluded that Camellia Sinensis Leaf–derived ingredients are safe as used in cosmetic products when formulated to be nonsensitizing. |
Ingredients Reviewed
The review scope matters because CIR conclusions often apply to an ingredient family rather than a single INCI name. In this report, the ingredient list includes Camellia sinensis– Derived Ingredients.
Safety Conclusion
The conclusion for Camellia sinensis– Derived Ingredients should be read as a CIR panel conclusion, not a regulatory limit. CIR assessments summarize expert-panel safety determinations for cosmetic use, while legal status still depends on the jurisdiction and product category.
Formulation Reading
For formula review, begin with the exact INCI identity and the ingredient group covered by the CIR assessment. If the material is Camellia sinensis– Derived Ingredients, the relevant comparison is whether the intended use aligns with the practices, concentration ranges, and conditions described in the CIR source.
The ingredient hub at Camellia sinensis– Derived Ingredients should carry the substance-level profile. This page is the report-level summary, keeping the conclusion, ingredient scope, and use-context language attached to the CIR source rather than treating the conclusion as a universal permission.
Why This Page Exists
CIR reviews are long documents, and the practical answer is usually buried in the conclusion and the table of current practices. This summary keeps those CIR facts in one indexable page for Camellia sinensis– Derived Ingredients, with source details retained at the bottom for audit.
Review Notes
The conservative reading is to keep Camellia sinensis– Derived Ingredients tied to the exact CIR report listed below. The ingredient family, panel conclusion, date, and any use-condition language belong together. A shorter ingredient-page snippet would lose that context.
This page gives the search-level answer while preserving the source-level caveat: CIR safety language is a panel assessment for cosmetic practices of use, not a universal legal permission across every jurisdiction or product category.
Source
- CIR report: Safety Assessment of Camellia sinensis– Derived Ingredients As Used in Cosmetics Lillian C. Becker1, Wilma F. Bergfeld2, Donald V. Belsito2, Ronald A. Hill2, Curtis D. Klaassen2, Daniel C. Liebler2, James G. Marks Jr2, Ronald C. Shank2, Tho
- CIR source file: PRS658.pdf
- Extraction JSON: Source documentation archived.
- Conclusion page in CIR extraction: 19